Decera Clinical Education Pharmacy Practice Podcast

In this episode, pharmacists Megan Adelman, PharmD, BCPS, BCGP, CDCES, and Elizabeth Pogge, PharmD, MPH, BCPS-AQ Cardiology, BCGP, FASCP, FAzPA, provide an overview of obesity, including pathophysiology and the benefits of long-term weight loss, and discuss guideline recommendations for treatment, pharmacotherapy options including injectable agents, and overcoming barriers to care.Presenters:Megan Adelman, PharmD, BCPS, BCGP, CDCESFamily Medicine Clinical SpecialistCenter for Family

FacultyTyree H. Kiser, PharmD, FCCM, FCCP, BCCCP, BCPSProfessor, Department of Clinical PharmacyUniversity of Colorado Skaggs School of Pharmacy and Pharmaceutical SciencesCritical Care Pharmacy Specialist, Department of PharmacyUniversity of Colorado HospitalAurora, ColoradoCharles E. “Kurt” Mahan, PharmD, PhC, FASHP, FCCPAdjunct Associate Professor, PharmacyUniversity of New Mexico Health Sciences CenterAlbuquerque, New Mexico  Content based on a CE activity supported by an educational grant from

1:08 - Take-home thoughts for R/R MM 3:47 - Summary of BCMA-targeted CAR T-cell therapy; Use of novel agents for R/R MM6:47 - Information on melphalan flufenamide; Combination approaches with selinexor in clinical practice9:59 - Cost considerations for treatment options in R/R MM12:25 - Administration considerations for subcutaneous daratumumab and venetoclax in R/R MMFacultyKathryn Maples, PharmD, BCOPClinical Pharmacy Specialist, Multiple MyelomaWinship Cancer Institute, Emory HealthcareAtlanta,